- Research works
- 17 ▲ 555% vs 2013–17
- Citations
- 50 2.9 per fractional work
- Top-10% rate
- 5.7% record average 16.5%
- Open access
- 75% world 28%
Not ranked overall: AstraZeneca (Portugal) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 4.3×. Every wedge is a field page.
Which research topics does AstraZeneca (Portugal) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Heart Failure Treatment and Management, Health Systems, Economic Evaluations, Quality of Life and Asthma and respiratory diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 2 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 4 Asthma and respiratory diseases Physiology 1 works
- 5 Medication Adherence and Compliance Family Practice 1 works
- 6 Health Literacy and Information Accessibility General Health Professions 0 works
- 7 Delphi Technique in Research Sociology and Political Science 0 works
- 8 Dialysis and Renal Disease Management Nephrology 0 works
- 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 10 Pancreatic and Hepatic Oncology Research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AstraZeneca (Portugal)'s research output changed?
Output in 2018–2022 was 555% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Barcarena
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.